Endothelial dysfunction in patients with non-alcoholic fatty liver disease

Purpose of the study: The aim of the studyis to study the vascular response in response to a test of reactive hyperemia in patients with NAFLD and to identify the relationship of fatty liver damage with endothelial dysfunction. Methods: The study was conducted on the basis of the Irkutsk Regional Order of the Badge of Honor Clinical Hospital, the Angarsk City Clinical Hospital No. 1 and the Consultative and Diagnostic Department No. 1 of the Irkutsk Regional Infectious Diseases Clinical Hospital. Object of study: patients with NAFLD and practically healthy volunteers. All respondents underwent indirect elastometry to diagnose liver fibrosis, and to assess endothelial dysfunction, a sample of reactive hyperemia according to the Celermajer method [15]. Statistical analysis of the data obtained was performed in the program Statistica 13 for Windows. Results: The study was conducted in the period 2014-2016. Examined 64 people aged 25 to 64 years with a confirmed diagnosis of NAFLD and 23 practically healthy volunteers aged 25 to 44 years included in the clinical comparison group. Conclusions: 1. Fibrous changes in the liver were more common among middle-aged people and were more pronounced than among younger people; 2. The correlation of fatty liver damage with endothelial dysfunction was revealed - the greater the degree of fibrosis, the stronger the pathological reaction of the vascular wall; 3. The presence of endothelial dysfunction in steatosis has been proven, and, accordingly, the risk of cardiovascular events. Conclusion: the results obtained indicate the connection of pathological processes: liver damage in NAFLD and the development of CVD.

non-alcoholic fatty liver disease (NAFLD), fibrosis, cardiovascular diseases (CVD), steatohepatitis, steatosis, endothelial dysfunctio

1. Bueverov A.O., Maevskaya M. V. Some pathogenetic and clinical issues of nonalcoholic steatohepatitis. Clinical Prospects of Gastroenterology, Hepatology. 2003;(3):2-7. (in Russ.) @@Буеверов А. О., Маевская М. В. Некоторые патогенетические и клинические вопросы неалкогольного стеатогепатита // Клинические перспективы гастроэнтерологии, гепатологии. - 2003. - № 3. - С. 2-7.

2. Drapkina O.M., Gatsolaeva D. S., Ivashkin V. T. Nonalcoholic fatty liver disease in patients with metabolic syndrome. The clinician. 2007;(6):46-50. (in Russ.) @@Драпкина О. М., Гацолаева Д. С., Ивашкин В. Т. Неалкогольная жировая болезнь печени у больных с метаболическим синдромом // Клиницист. - 2007. - № 6. - C. 46-50.

3. Younossi Z. M. Non-alcoholic fatty liver disease - a global public health perspective. J. Hepatol. 2019;70:531-544. doi: 10.1016/j.jhep.2018.10.033

4. Ivashkin V.T., Maevskaya M. V., Pavlov C. S., et al. Clinical guidelines for the diagnosis and treatment of nonalcoholic fatty liver disease of the Russian Society for the Study of the Liver and the Russian Gastroenterological Association.Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2016;26(2):24-42. (in Russ.) doi: 10.22416/1382-4376-2016-26-2-24-42 @@Ивашкин В. Т., Маевская М. В., Павлов Ч. С., Тихонов И. Н., Широкова Е. Н., Буеверов А. О. и др. Клинические рекомендации по диагностике и лечению неалкогольной жировой болезни печени Российского общества по изучению печени и Российской гастроэнтерологической ассоциации. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2016;26(2):24-42. doi: 10.22416/1382-4376-2016-26-2-24-42

5. Tirikova O.V., Kozlova N. M., Tarasov A. U., Eliseev S. M., Lunenok S. V. Autopsy incidence rate of fatty liver disease in the Irkutsk region. Experimental and Clinical Gastroenterology. 2020;176(4): 72-76. (In Russ.) doi: 10.31146/1682-8658-ecg-176-4-72-76 @@Тирикова О. В., Козлова Н. М., Тарасов А. Ю., Елисеев С. М., Луненок C. В. Частота встречаемости жировой болезни печени в Иркутской области по результатам аутопсий. Экспериментальная и клиническая гастроэнтерология. 2020;176(4): 72-76. doi: 10.31146/1682-8658-ecg- 176-4-72-76

6. Ong J.P., Pitts A., Younossi Z. M. Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease. Journal of Hepatology. 2008;49 (4):608-612. doi: 10.1016/j.jhep.2008.06.018

7. Adams L.A., Lymp J. F., Sauver J. St., Sanderson S. O., Lindor K. D., Feldstein A., et al. The natural history of nonalcoholic fatty liver disease: a population based cohort study. Gastroenterology. 2005;129 (1):113-121. doi: 10.1053/j.gastro.2005.04.014

8. Rafiq N., Bai C., Fang Y., Srishord M., McCullough A., Gramlich T., et al. Long term follow-up of patients with nonalcoholic fatty liver. Clinical Gastroenterology and Hepatology. 2009;7:234-238. doi: 10.1016/j.cgh.2008.11.005

9. Medina J., Fernández-Salazar L.I., García-Buey L., Moreno-Otero R. Approach to the pathogenesis and treatment of nonalcoholic steatohepatitis. Diabetes Care. 2004;27(8):2057-2066. doi: 10.2337/diacare.27.8.2057

10. Fennessy F. M. Moneley D. S., Wang J. H., Kelly C. J., Bouchier-Hayeset D. J. Taurine and Vitamin C Modify Monocyte and Endothelial Dysfunction in Young Smokers. Circulation. 2003;(107):410-415. (pp. 926-928.) doi: 10.1161/01.cir.0000046447.72402.47

11. Lavi Sh., Egbarya R., Lavi R., Jacobet G. Role of Nitric Oxide in the Regulation of Cerebral Blood Flow in Humans. Circulation. 2003;(107): 1901-1905. doi:10.1161/01.CIR.0000057973.99140.5A

12. Pollock D. M., Polakowski J. S., Opgenorth T. J., Pollock J. S. Role of endothelin ET (A) receptors in the hypertension produced by 4-day L-nitroarginine methyl ester and cyclosporine treatment. Eur. J. Pharmacol. 1998;346(1):43-50. doi: 10.1016/s0014-2999(98)00043-0

13. Wattanpitayakul S. K., Weinstein D. M., Holyc ross B.J., Bauer J. A. Endothelial dysfunction and peroxynitrite formation are early events in angiotensin - induced cardiovascular disorders. FASEB J. 2000;14(2):271-278. doi:10.1096/fasebj.14.2.271

14. Fracanzani A.L., Burdick L., Raselli S., Pedotti P., Grigore L., Santorelli G., et al. Carotid artery intima-media thickness in nonalcoholic fatty liver disease. American Journal of Medicine. 2008;121:72-78. doi: 10.1016/j.amjmed.2007.08.041

15. Celermajer D. S., Sorensen K. E., Gooch V. M., Spiegelhalter D. J., Miller O. I., Sullivan I. D., et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992; 340 (8828):1111-1115. doi: 10.1016/0140-6736(92)93147